Thermo Fisher Scientific Completes Large-Scale Proteomic Analysis for Landmark Parkinson’s Disease Study Thermo Fisher Scientific Inc., a global leader in scientific research services and technologies, has announced the completion of…
Adagio Medical Reports Second-Quarter 2026 Results as Ventricular Tachycardia Program Advances Toward FDA Review Adagio Medical Holdings, Inc., a medical technology company focused on developing innovative catheter ablation solutions for…
GeneDx Launches Online Exome Testing Offering to Expand Access to Genetic Diagnosis for Children GeneDx , a leader in rare disease diagnosis and genomic data, has announced the launch of…
ILiAD Biotechnologies Strengthens Leadership Team With Veteran Vaccine Executives as BPZE1 Advances Toward Late-Stage Development ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical-stage biotechnology company focused on developing innovative approaches to…
BioVigil Surpasses 1 Billion Hand Hygiene Opportunities, Highlighting Continued Focus on Infection Prevention and Patient Safety BioVigil, a leading provider of automated hand hygiene monitoring and infection prevention technology, has…
ImmunityBio Appoints Global Health Leader Dr. Jim Yong Kim as Vice Chairman to Strengthen International Partnerships and Expand Global Healthcare Access ImmunityBio, Inc., a commercial-stage biotechnology company focused on developing…
ACCESS and Johnson & Johnson Announce Multi-Year Agreement to Expand Advanced Cardiac Electrophysiology Technologies in U.S. Ambulatory Surgery Centers ACCESS, through its physician-led group purchasing organization, ACCESS Group Purchasing Organization…
AbCellera Reports Positive Phase 2 Results for ABCL635, Advancing Long-Acting Non-Hormonal Treatment for Menopausal Hot Flashes AbCellera has announced encouraging top-line results from the Phase 2 portion of its ongoing…
Bruker Expands Drug Discovery Capabilities with Majority Investment in MIMETAS and Organ-on-a-Chip Technology Bruker Corporation has announced a majority investment in MIMETAS B.V., a biotechnology company specializing in organ-on-a-chip platforms…
BeOne Medicines and Revolution Medicines Announce Broad Oncology Collaboration to Advance RAS-Targeted Therapies BeOne Medicines Ltd. and Revolution Medicines, Inc. have announced a multi-part strategic collaboration aimed at expanding treatment…
Innate Pharma and Sobi Partner to Advance Lacutamab into Phase 3 Development for Cutaneous T-Cell Lymphoma Innate Pharma SA and Swedish Orphan Biovitrum AB (publ), widely known as Sobi®, have…
Cerepeut Study in Neuron Identifies Mitochondrial Mechanism Driving Tau-Related Neurodegeneration and Highlights CP-235 as Potential Therapy Cerepeut, Inc., a biotechnology company focused on developing mitochondrial therapeutics for neurodegenerative diseases, has…